NX Prenatal
Louisville
About NX Prenatal
NX Prenatal is a private molecular diagnostics company developing diagnostic assays for adverse pregnancy conditions such as preterm birth. It employs the proprietary NeXosome platform, which enables advanced isolation and enrichment of exosome and microvesicle particles from bodily fluids for non-invasive biomarker evaluation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $8.1M
- Last round: Series Unknown (Aug 2023)
- Website: nxprenatal.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/nx-prenatal-28558 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.